Effective photodynamic therapy with ir(Iii) for virulent clinical isolates of extended-spectrum beta-lactamase klebsiella pneumoniae
Date Issued
2021-05
Author(s) USM
Dreyse, Paulina
DOI
10.3390/pharmaceutics13050603
Abstract
Background: The extended-spectrum beta-lactamase (ESBL) Klebsiella pneumoniae is one of the leading causes of health-associated infections (HAIs), whose antibiotic treatments have been severely reduced. Moreover, HAI bacteria may harbor pathogenic factors
